• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
How the Medicare Part D drug benefit changed the distribution of out-of-pocket pharmacy spending among older beneficiaries.医疗保险处方药福利如何改变老年受益人的自付药房支出分布。
J Gerontol B Psychol Sci Soc Sci. 2010 Jul;65(4):502-7. doi: 10.1093/geronb/gbp111. Epub 2009 Dec 14.
2
Effects of Medicare Part D on drug affordability and use: Are seniors with prior high out-of-pocket drug spending affected more?医疗保险处方药部分对药物可负担性和使用的影响:是否有先前高自付药物支出的老年人受到的影响更大?
Res Social Adm Pharm. 2010 Jun;6(2):90-9. doi: 10.1016/j.sapharm.2010.02.004.
3
Implementation of Medicare Part D and nondrug medical spending for elderly adults with limited prior drug coverage.有有限既往药物覆盖的老年成年人的医疗保险部分 D 和非药物医疗支出的实施。
JAMA. 2011 Jul 27;306(4):402-9. doi: 10.1001/jama.2011.1026.
4
Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes.陷入覆盖缺口:有糖尿病的医疗保险优势处方药计划受益人的 Part D 药物费用和依从性。
Health Serv Res. 2010 Apr;45(2):355-75. doi: 10.1111/j.1475-6773.2009.01071.x. Epub 2009 Dec 30.
5
Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs.分析拟议的医疗保险 B 部分到 D 部分的转变以及处方药总支出和患者自付费用的相关变化。
JAMA Intern Med. 2019 Mar 1;179(3):374-380. doi: 10.1001/jamainternmed.2018.6417.
6
The Impact of Medicare Part D on the Proportion of Out-of-Pocket Prescription Drug Costs Among Older Adults With Diabetes.医疗保险处方药部分对老年糖尿病患者自付处方药费用比例的影响。
Diabetes Care. 2017 Apr;40(4):502-508. doi: 10.2337/dc16-0902. Epub 2016 Nov 1.
7
Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.医疗保险D部分实施前后青光眼弱势受益人群中处方药覆盖范围参保情况的变化
JAMA Ophthalmol. 2016 Feb;134(2):212-20. doi: 10.1001/jamaophthalmol.2015.5090.
8
Specialty drug spending trends among Medicare and Medicare Advantage enrollees, 2007-11.2007 - 2011年医疗保险和医疗保险优势计划参保者的特种药物支出趋势
Health Aff (Millwood). 2014 Nov;33(11):2018-24. doi: 10.1377/hlthaff.2014.0538.
9
The effect of Medicare Part D on drug and medical spending.医疗保险处方药计划(Medicare Part D)对药品和医疗支出的影响。
N Engl J Med. 2009 Jul 2;361(1):52-61. doi: 10.1056/NEJMsa0807998.
10
Prescription coverage, use and spending before and after Part D implementation: a national longitudinal panel study.处方覆盖范围、使用和支出在 Part D 实施前后:一项全国纵向面板研究。
J Gen Intern Med. 2010 Jan;25(1):10-7. doi: 10.1007/s11606-009-1134-2. Epub 2009 Oct 31.

引用本文的文献

1
What Interventions Work to Reduce Cost Barriers to Primary Healthcare in High-Income Countries? A Systematic Review.哪些干预措施有助于减少高收入国家初级医疗保健的费用障碍?系统评价。
Int J Environ Res Public Health. 2024 Aug 5;21(8):1029. doi: 10.3390/ijerph21081029.
2
Pharmaceutical policies: effects of regulating drug insurance schemes.药品政策:规范药品保险计划的影响
Cochrane Database Syst Rev. 2022 May 3;5(5):CD011703. doi: 10.1002/14651858.CD011703.pub2.
3
Variation in generic dispensing rates in Medicare Part D.医疗保险处方药中仿制药配给率的差异。
Am J Manag Care. 2020 Nov 1;26(11):e355-e361. doi: 10.37765/ajmc.2020.88530.
4
The impact of Medicare part D on income-related inequality in pharmaceutical expenditure.医疗保险 D 部分对药品支出与收入相关不平等的影响。
Int J Equity Health. 2019 Apr 16;18(1):57. doi: 10.1186/s12939-019-0955-9.
5
Medicare Part D's Effects on Drug Utilization and Out-of-Pocket Costs: A Systematic Review.医疗保险D部分对药物使用和自付费用的影响:一项系统评价。
Health Serv Res. 2017 Oct;52(5):1685-1728. doi: 10.1111/1475-6773.12534. Epub 2016 Aug 1.
6
Pharmaceutical policies: effects of cap and co-payment on rational use of medicines.药品政策:封顶价和共付额对合理用药的影响。
Cochrane Database Syst Rev. 2015 May 8;2015(5):CD007017. doi: 10.1002/14651858.CD007017.pub2.
7
Pharmaceutical Cost-Saving Strategies and their Association with Medication Adherence in a Medicare Supplement Population.医保补充人群中的药品成本节约策略及其与药物依从性的关联
J Gen Intern Med. 2015 Aug;30(8):1208-14. doi: 10.1007/s11606-015-3196-7. Epub 2015 Feb 10.
8
Racial differences in antilipemic use and lipid control in high-risk older adults: post-Medicare Part D.高风险老年人在使用降脂药和控制血脂方面的种族差异:医疗保险部分 D 之后。
Am Heart J. 2013 Oct;166(4):792-7. doi: 10.1016/j.ahj.2013.07.001. Epub 2013 Aug 28.
9
Medicare Part D and potentially inappropriate medication use in the elderly.医疗保险 D 部分与老年人潜在不适当药物使用。
Am J Manag Care. 2012 Sep 1;18(9):e315-22.
10
Just because it's low cost doesn't mean it's accessible.仅仅因为成本低并不意味着它易于获取。
J Gen Intern Med. 2012 Oct;27(10):1233-4. doi: 10.1007/s11606-012-2151-0.

本文引用的文献

1
The effect of Medicare Part D on drug and medical spending.医疗保险处方药计划(Medicare Part D)对药品和医疗支出的影响。
N Engl J Med. 2009 Jul 2;361(1):52-61. doi: 10.1056/NEJMsa0807998.
2
The effects of the coverage gap on drug spending: a closer look at Medicare Part D.保险覆盖缺口对药品支出的影响:以 Medicare Part D 为例。
Health Aff (Millwood). 2009 Mar-Apr;28(2):w317-25. doi: 10.1377/hlthaff.28.2.w317. Epub 2009 Feb 3.
3
Medicare Part D's effects on elderly patients' drug costs and utilization.医疗保险D部分对老年患者药品费用和使用情况的影响。
Am J Manag Care. 2008 Nov;14(11 Suppl):SP14-22.
4
The effect of the Medicare Part D prescription benefit on drug utilization and expenditures.医疗保险D部分处方药福利对药物使用和支出的影响。
Ann Intern Med. 2008 Feb 5;148(3):169-77. doi: 10.7326/0003-4819-148-3-200802050-00200. Epub 2008 Jan 7.
5
The impact of Medicare Part D on prescription drug use by the elderly.医疗保险D部分对老年人处方药使用的影响。
Health Aff (Millwood). 2007 Nov-Dec;26(6):1735-44. doi: 10.1377/hlthaff.26.6.1735.
6
How the new medicare drug benefit could affect vulnerable populations.新的医疗保险药品福利将如何影响弱势群体。
Health Aff (Millwood). 2006 Jan-Feb;25(1):248-55. doi: 10.1377/hlthaff.25.1.248.

医疗保险处方药福利如何改变老年受益人的自付药房支出分布。

How the Medicare Part D drug benefit changed the distribution of out-of-pocket pharmacy spending among older beneficiaries.

机构信息

Department of Health Policy & Management, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA.

出版信息

J Gerontol B Psychol Sci Soc Sci. 2010 Jul;65(4):502-7. doi: 10.1093/geronb/gbp111. Epub 2009 Dec 14.

DOI:10.1093/geronb/gbp111
PMID:20008482
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2883868/
Abstract

OBJECTIVE

To examine the impact of the Medicare drug benefit (Part D) on the distribution of out-of-pocket pharmacy spending among older adults.

METHODS

We used a pre-post-with-comparison-group design to compare four groups of beneficiaries continuously enrolled in a Medicare Advantage plan between 2004 and 2007: three intervention groups with no or limited (quarterly caps of $150 or $350) prior coverage that obtained Part D benefits in 2006 and a comparison group with stable drug coverage from 2004 to 2007.

RESULTS

The comparison group's out-of-pocket drug spending was stable throughout 2004-2007, whereas Part D reduced out-of-pocket spending 13.4% among those without prior coverage (95% confidence interval [CI] -17.1% to -9.1%) and 15.9% among those with $150 quarterly caps (95% CI -19.1% to -12.8%) relative to the comparison group. Individuals in the top decile of drug spending paid a greater share of their costs out-of-pocket than others in the top 5 deciles.

DISCUSSION

Although Part D reduced out-of-pocket expenditures for older adults, those with the highest drug spending still pay a substantial share of their drug costs out-of-pocket. Thus, the Part D benefit does not achieve a primary purpose of insurance-to offer the greatest financial protection to those at the highest risk.

摘要

目的

考察医疗保险药品福利计划(Part D)对老年人自付药房支出分配的影响。

方法

我们采用了预-后-对照组设计,比较了 2004 年至 2007 年间连续参加医疗保险优势计划的四组受益人:三组干预组在 2006 年获得了 Part D 福利,但之前的覆盖范围有限(每季度 150 美元或 350 美元的上限),一组对照组在 2004 年至 2007 年期间保持稳定的药物覆盖范围。

结果

对照组的自付药物支出在 2004-2007 年期间保持稳定,而没有先前覆盖范围的人(95%置信区间 [CI] -17.1%至-9.1%)和有 150 美元季度上限的人(95%CI -19.1%至-12.8%),Part D 降低了自付药物支出相对对照组而言。在药物支出最高的十分位数中,个人自付的费用占其成本的比例高于其他五分位数中的其他人。

讨论

尽管 Part D 降低了老年人的自付支出,但那些药物支出最高的人仍然自付了相当大一部分药物费用。因此,Part D 福利并没有实现保险的主要目的-为风险最高的人提供最大的财务保护。